'Lindstrom To Expand Its Footprints In India'
Express Healthcare|July, 2017

Anupam Chakrabarty, MD, Lindstrom India, divulges that his company is now looking for new opportunities in tier I and tier II cities of India to expand its presence in healthcare segments like smaller clinics and diagnostic centres, in an interview with Prathiba Raju

Prathiba Raju
'Lindstrom To Expand Its Footprints In India'

Hygiene of the work environment and work wear is extremely important in the healthcare and pharma sectors. How does Lindstrom help ensure utmost hygiene?

As a business house, Lindstrom is completing 170 years of its existence next year. As for our operations in India, we started it in 2007 and our first unit was in Chennai. In India, we concentrate on two segments: one is pharma and other one is the food sector. We have our presence in 11 states which includes pharma industrial hubs of India like Baddi, Hyderabad, Ahmedabad, Pune, Bengaluru, Mumbai and Visakhapatanam. We have our facility in Assam as many pharma and FMCG companies are investing in the state. This is one segment where the hygiene levels are very critical and the standards of work wear are clearly compiled; there are lot of standards that exist. There are USFDA, MHRA audits so all the clients are subjected to some kind of external audits to some sort of external audits. So, a work wear company like Lindstrom has a huge role to play, 35 per cent of our business today is from the pharma sector. As far as health is concerned, it has two parts, one is the hospitals and the other is healthcare centres like clinics, diagnostic centres. As of now, our activities in the healthcare sector is focused on clinics and diagnostics, we are not formally getting down to the larger hospital chains as it needs a lot of compliance activities.

How important is the pharma sector for you?

この記事は Express Healthcare の July, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Express Healthcare の July, 2017 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

EXPRESS HEALTHCAREのその他の記事すべて表示
Healthcare Communication In India
Express Healthcare

Healthcare Communication In India

Dr Alexander Thomas, President, Association of Healthcare Providers - India (AHPI) and Divya Alexander, Research Consultant, in a first of a series provide detailed insights on healthcare communication that explores its different aspects in an Indian context

time-read
6 分  |
March 2020
The growth story
Express Healthcare

The growth story

Himanshu Baid, Managing Director, Poly Medicure elucidates on how Poly Medicure has served the medical fraternity for over 22 years and owns more than 215 patents and continues to file new patents for new technologies and devices they are developing with the help of its R&D team

time-read
2 分  |
March 2020
Main objective of Indian Joint Registry is to help patient safety, bring stability to the market
Express Healthcare

Main objective of Indian Joint Registry is to help patient safety, bring stability to the market

In the wake of several patients suffering from the impact of faulty hip implants, it is vital that India has a national joint registry to track such patients and avoid future episodes. Richard Armstrong, Head, Health Registries, Northgate Public Services tells Viveka Roychowdhury about the response to the Indian Joint Registry

time-read
4 分  |
March 2020
Express Healthcare

UNDERSTANDING THE RELEVANCE OF HEALTHCARE RESEARCH

India as a nation has followed the west for decades when it comes to research-based treatments. The sun is fast setting on this methodology and there is a massive need to invest in healthcare research in the country

time-read
8 分  |
March 2020
I have witnessed the steady technical advances in ultrasound
Express Healthcare

I have witnessed the steady technical advances in ultrasound

Dr BS Rama Murthy, Consultant Radiologist, Srinivasa Ultrasound Scanning Centre and Chief Patron, Medical Ultrasound Society of Karnataka, Coordinator – Fetal Foundation of India, talks about the evolution of ultrasound and how foetal imaging has improved over the years, in an interaction with Express Healthcare

time-read
4 分  |
March 2020
Radiology has a bright future and has been at the forefront of healthcare
Express Healthcare

Radiology has a bright future and has been at the forefront of healthcare

Radiology has a major role to play when it comes to healthcare. Dr Piyush Saxena, Consultant Radiologist and Chief of MR imaging, Vishesh Hospital and Diagnostics, Indore, MP in an exclusive conversation with Express Healthcare disscuses the impact of radiology on healthcare and how newer innovations from GE Healthcare has helped improve healthcare delivery as well as patient comfort

time-read
4 分  |
March 2020
The Pill For India's Ailing Medical Eductaion System
Express Healthcare

The Pill For India's Ailing Medical Eductaion System

Medical education in India is mired with a host of controversies and is trudging along a rough path.

time-read
6 分  |
February 2020
RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai
Express Healthcare

RED INITIATIVE - Canon Medical / Erbis Engineering conducts CME programmes on CTO-PCIs in Chennai

Invites renowned Japanese cardiac interventionist, Dr Kinzo Ueda to India to share his experiences and insights with cardiologists at Apollo Hospitals and Sri Ramachandra Institute of Higher Education and Research

time-read
8 分  |
February 2020
Roche Diagnostics partners with SRL Dr Avinash Phadke Lab
Express Healthcare

Roche Diagnostics partners with SRL Dr Avinash Phadke Lab

Roche’s first partner for cobas pro solution is SRL Dr Avinash Phadke Lab in Mumbai. The solution promises to offer greater automation, flexibility and simplified workflow to support better clinical outcomes for patients

time-read
5 分  |
February 2020
Pharmacogenomics- Essential to end the era of trial and error medicine
Express Healthcare

Pharmacogenomics- Essential to end the era of trial and error medicine

Chandni Luthra, Co-Founder, FutureMed elucidates on the impact that trial and error has had on patients earlier, but in today's age adverse drug reactions is considered to be the fourth leading cause of death worldwide and has almost doubled in India in the last three years

time-read
3 分  |
February 2020